Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
Alison Luckey(Global Antibiotic Research & Development Partnership), Stephanie E. Cohen(Department of Human Services), Magnus Unemo(Örebro University), Drew Lewis(Innoviva (United States)), Katherine Gill(Desmond Tutu HIV Foundation), Chris Kenyon(Instituut voor Tropische Geneeskunde), Elizabeth Spooner(South African Medical Research Council), Stephanie N. Taylor(Louisiana State University Health Sciences Center New Orleans), Nittaya Phanuphak(HIV Netherlands Australia Thailand Research Collaboration), John P. Mueller(Innoviva (United States)), Manica Balasegaram(Global Antibiotic Research & Development Partnership), Teresa A. Batteiger(Indiana University School of Medicine), Edward W. Hook(University of Alabama at Birmingham), Henry J.C. de Vries(Amsterdam Neuroscience), Jodie Dionne‐Odom(University of Alabama at Birmingham), Lindley A. Barbee, Helen Broadhurst(Knutsford and District Community Hospital), Rossaphorn Kittiyaowamarn(Ministry of Public Health), Zinhle Zwane(Setshaba Research Centre), John P. O’Donnell(Entasis Therapeutics (United States)), Seamus O’Brien(Pfizer (United States)), Vimla Naicker(South African Medical Research Council), Sinead Delany‐Moretlwe(University of the Witwatersrand)
Cited by 26
Related Papers
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Invasion of the Central Nervous System by <i>Treponema pallidum:</i> Implications for Diagnosis and Treatment
|Annals of Internal Medicine|1988|601
Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium
|Nature Medicine|2022|270
Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters — Four U.S. Cities, March 27–April 15, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|240
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
|New England Journal of Medicine|2021|231